Recommendations for the Management of Herpes ZosterRobert H. Dworkin, Richard J. Whitley, Robert W. Johnson et al.|Clinical Infectious Diseases|2006Cited by 842
Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV VaccineMyron J. Levin, Michael J. Caulfield, Jeffrey G. Smith et al.|The Journal of Infectious Diseases|2003Cited by 320
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventoryPaul Coplan, Michael N. Oxman, Harry A. Guess et al.|Journal of Pain|2004Cited by 304
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised hostJoel D. Meyers, Henry H. Balfour, James C. Wade et al.|The American Journal of Medicine|1982Cited by 263
Human Sensory Neurons Derived from Induced Pluripotent Stem Cells Support Varicella-Zoster Virus InfectionKatherine S. Lee, Myron J. Levin|PLoS ONE|2012Cited by 81